Abstract:Intracerebral hemorrhage (ICH) is the most fatal form of acute stroke, with 17.9 million patients worldwide, accounting for 10–15% of all stroke patients [ 1 ]. Despite treatments such as surgical hematoma evacuation and blood pressure management, mortality from ICH remains as high as 68% [ 1 ]. ICH-induced injuries are classified into primary injuries and secondary injuries. The primary injury was related to the mass effect caused by initial hematoma, hematoma expansion and hydrocephalus. Secondary brain injury is caused by microglia activation, which drives inflammatory, oxidative and cytotoxic reactions that further lead to cell death and dysfunction [ 2 ]. After ICH, reactive oxygen species (ROS) act as mediators of demyelination and blood-brain barrier disruption, causing mitochondrial dysfunction, and may be involved in the development of early and late brain edema. A recent multicenter clinical trial confirmed that early hematoma removal after ICH does not effectively improve patient prognosis [ 3 ]. In addition to limited progress in the management of ICH patients, effective treatment options are yet to be developed for the secondary brain injury of ICH.

Electroacupuncture reduces oxidative stress response and improves secondary injury of intracerebral hemorrhage in rats by activating the peroxisome proliferator-activated receptor-γ/nuclear factor erythroid2-related factor 2/γ-glutamylcysteine synthetase pathway